A new peptide should enter the practice through a defined service-line review — not because a vendor added it to a catalog or patients started asking.
Clinical governance reviewed by Armando A Falcon, MD (FL ME 84789) · Florida regulatory framework reviewed August 2026.
A new peptide should enter the practice through a defined service-line review — not because a vendor added it to a catalog or patients started asking for it. Before it reaches the menu, the clinic should confirm the specific product and the clinical, prescribing, pharmacy, evaluation, documentation, and monitoring structure around it.
Exact substance and formulation; intended clinical use; available evidence; who will prescribe; pharmacy/source; route; patient-evaluation pathway; documentation; monitoring; adverse-event escalation; current pharmacy/compounding considerations; staff responsibilities; and patient communication.
Patient demand can start the conversation. It should not finish the governance review. This is where MFMD’s service-line development fits — see Add a Service Line.
Disclaimer — B2B clinical-governance & compliance education only. This content is general business, clinical-governance, and compliance information for healthcare practices. It does not create a physician-patient relationship, provide patient-specific medical advice or prescribing authority, or constitute legal advice. Requirements vary by ownership, services offered, provider credentials, payer model, facility type, and whether a practice is licensed or exempt — clinics remain responsible for independently verifying the current laws, rules, and professional requirements that apply to their structure and services before implementation.
FDA — bulk drug substances used in compounding under §503A
FDA — compounding and the FDA: questions and answers
Florida Statutes Chapter 465 — Pharmacy Act (compounding & dispensing)
Peptide & Wellness — medical director services
All Florida medical-director resources
Medical director services across selected Central, South, and Gulf Coast Florida markets — Miami & Fort Lauderdale, Palm Beach County, Orlando, Tampa Bay, Sarasota & Bradenton, Fort Myers & Naples. See areas we serve. Clinic acceptance and physician availability are confirmed for each location.
Under the medical direction of Armando A Falcon, MD (FL ME 84789). Serving approved Central, South, and Gulf Coast Florida markets; clinic acceptance and physician availability confirmed individually. Call or WhatsApp +1 (305) 877-7507.